Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5O14

Co-crystal structure of a cross-reactive bactericidal human antibody targeting meningococcal vaccine antigen factor H binding protein

5O14 の概要
エントリーDOI10.2210/pdb5o14/pdb
分子名称Factor H binding protein variant 1.1, Fab 1A12 Heavy Chain, Fab 1A12 Light Chain, ... (6 entities in total)
機能のキーワードhuman fab, factor h binding protein, outer membrane, infection, immune system
由来する生物種Neisseria meningitidis serogroup B (strain MC58)
詳細
タンパク質・核酸の鎖数6
化学式量合計153920.80
構造登録者
Lopez-Sagaseta, J. (登録日: 2017-05-18, 公開日: 2018-02-14, 最終更新日: 2024-11-13)
主引用文献Lopez-Sagaseta, J.,Beernink, P.T.,Bianchi, F.,Santini, L.,Frigimelica, E.,Lucas, A.H.,Pizza, M.,Bottomley, M.J.
Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbp.
Nat Commun, 9:528-528, 2018
Cited by
PubMed Abstract: Data obtained recently in the United Kingdom following a nationwide infant immunization program against serogroup B Neisseria meningitidis (MenB) reported >80% 4CMenB vaccine-mediated protection. Factor H-binding protein (fHbp) is a meningococcal virulence factor and a component of two new MenB vaccines. Here, we investigated the structural bases underlying the fHbp-dependent protective antibody response in humans, which might inform future antigen design efforts. We present the co-crystal structure of a human antibody Fab targeting fHbp. The vaccine-elicited Fab 1A12 is cross-reactive and targets an epitope highly conserved across the repertoire of three naturally occurring fHbp variants. The free Fab structure highlights conformational rearrangements occurring upon antigen binding. Importantly, 1A12 is bactericidal against MenB strains expressing fHbp from all three variants. Our results reveal important immunological features potentially contributing to the broad protection conferred by fHbp vaccination. Our studies fuel the rationale of presenting conserved protein epitopes when developing broadly protective vaccines.
PubMed: 29410413
DOI: 10.1038/s41467-018-02827-7
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.195 Å)
構造検証レポート
Validation report summary of 5o14
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon